cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)

The protein contains 351 amino acids for an estimated molecular weight of 40590 Da.

 

Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VA (updated: June 17, 2020)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Wilson and co-workers. (2016) Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation. Mol Cell Proteomics. 15(6), 1938-1946.
  5. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  6. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.
  7. Chu and co-workers. (2018) Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation. Br J Haematol. 180(1), 118-133.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology, is annotated as membranous in UniProt.


Interpro domains
Total structural coverage: 100%
Model score: 100
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
dbSNP:rs56029020
dbSNP:rs56085217
PPNAD4
dbSNP:rs35635531

Biological Process

Activation of phospholipase C activity GO Logo
Activation of protein kinase A activity GO Logo
Adaptive immune response GO Logo
Blood coagulation GO Logo
Calcium-mediated signaling using intracellular calcium source GO Logo
Carbohydrate metabolic process GO Logo
Cell communication by electrical coupling involved in cardiac conduction GO Logo
Cellular response to epinephrine stimulus GO Logo
Cellular response to glucagon stimulus GO Logo
Cellular response to glucose stimulus GO Logo
Cellular response to heat GO Logo
Cellular response to parathyroid hormone stimulus GO Logo
Chemical synaptic transmission GO Logo
Ciliary basal body-plasma membrane docking GO Logo
Cytokine-mediated signaling pathway GO Logo
Energy reserve metabolic process GO Logo
Epidermal growth factor receptor signaling pathway GO Logo
Fibroblast growth factor receptor signaling pathway GO Logo
G2/M transition of mitotic cell cycle GO Logo
Gluconeogenesis GO Logo
Glucose metabolic process GO Logo
High-density lipoprotein particle assembly GO Logo
Innate immune response GO Logo
Intracellular signal transduction GO Logo
Mesoderm formation GO Logo
Mitotic cell cycle GO Logo
Modulation of chemical synaptic transmission GO Logo
MRNA processing GO Logo
Negative regulation of inflammatory response to antigenic stimulus GO Logo
Negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning GO Logo
Neural tube closure GO Logo
Neurotrophin TRK receptor signaling pathway GO Logo
Organelle organization GO Logo
Pathogenesis GO Logo
Peptidyl-serine phosphorylation GO Logo
Peptidyl-threonine phosphorylation GO Logo
Positive regulation of cell cycle arrest GO Logo
Positive regulation of protein export from nucleus GO Logo
Protein autophosphorylation GO Logo
Protein kinase A signaling GO Logo
Protein phosphorylation GO Logo
Regulation of bicellular tight junction assembly GO Logo
Regulation of cardiac conduction GO Logo
Regulation of cardiac muscle contraction GO Logo
Regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion GO Logo
Regulation of cytosolic calcium ion concentration GO Logo
Regulation of G2/M transition of mitotic cell cycle GO Logo
Regulation of heart rate GO Logo
Regulation of insulin secretion GO Logo
Regulation of macroautophagy GO Logo
Regulation of osteoblast differentiation GO Logo
Regulation of proteasomal protein catabolic process GO Logo
Regulation of protein binding GO Logo
Regulation of protein processing GO Logo
Regulation of ryanodine-sensitive calcium-release channel activity GO Logo
Renal water homeostasis GO Logo
Signal transduction GO Logo
Small molecule metabolic process GO Logo
Sperm capacitation GO Logo
Stimulatory C-type lectin receptor signaling pathway GO Logo
Transmembrane transport GO Logo
Triglyceride catabolic process GO Logo
Water transport GO Logo

The reference OMIM entry for this protein is 601639

Protein kinase, camp-dependent, catalytic, alpha; prkaca prkaca/dnajb1 fusion gene, included

DESCRIPTION

Most of the effects of cAMP in the eukaryotic cell are mediated through the phosphorylation of target proteins on serine or threonine residues by the cAMP-dependent protein kinase (EC 2.7.1.37). The inactive cAMP-dependent protein kinase is a tetramer composed of 2 regulatory and 2 catalytic subunits. The cooperative binding of 4 molecules of cAMP dissociates the enzyme in a regulatory subunit dimer and 2 free active catalytic subunits. In the human, 4 different regulatory subunits (PRKAR1A, 188830; PRKAR1B, 176911; PRKAR2A, 176910; and PRKAR2B, 176912) and 3 catalytic subunits (PRKACA; PRKACB, 176892; and PRKACG 176893) have been identified (summary by Tasken et al., 1996).

BIOCHEMICAL FEATURES

- Crystal Structure Kim et al. (2005) determined the crystal structure of the cAMP-dependent protein kinase catalytic subunit bound to a deletion mutant of the regulatory subunit (RI-alpha; PRKAR1A, 188830) at 2.0-angstrom resolution. This structure defines a previously unidentified extended interface in which the large lobe of the catalytic subunit is like a stable scaffold where tyr247 in the G helix and trp196 in the phosphorylated activation loop serve as anchor points for binding the RI-alpha subunit. These residues compete with cAMP for the phosphate-binding cassette in RI-alpha. In contrast to this catalytic subunit, RI-alpha undergoes major conformational changes when the complex is compared with cAMP-bound RI-alpha. Kim et al. (2005) concluded that the complex provides a molecular mechanism for inhibition of PKA and suggests how cAMP binding leads to activation. Zhang et al. (2012) described the 2.3-angstrom structure of full-length tetrameric RII-beta (PRKAR2B; 176912)(2):catalytic subunit-alpha(2) holoenzyme. The structure showing a dimer of dimers provided a mechanistic understanding of allosteric activation by cAMP. The heterodimers are anchored together by an interface created by the beta-4/beta-5 loop in the RII-beta subunit, which docks onto the carboxyl-terminal tail of the adjacent C subunit, thereby forcing the C subunit into a fully closed conformation in the absence of nucleotide. Diffusion of magnesium ATP into these crystals trapped not ATP but the reaction products adenosine diphosphate and the phosphorylated RII-beta subunit. This complex has implications for the dissociation-reassociation cycling of PKA. The quaternary structure of the RII-beta tetramer differs appreciably from the model of the RI-alpha tetramer, confirming the small-angle x-ray scattering prediction that the structures of each PKA tetramer are different.

MAPPING

Using PCR and Southern blot analysis, Tasken et al. (1996) assigned the PRKACA gene to chromosome 19. By 2-color fluorescence in situ hybridization, they regionalized the assignment to 19p13.1.

GENE FUNCTION

Studying hippocampal slices from rats of different ages, Yasuda et al. (2003) found that protein kinase A is required for long-term potentiation (LTP) in neonatal tissue (less than 9 postnatal days). After that time, LTP requires calcium/calmodulin-dependent protein kinase II (see CAMK2A, 114078). Yasuda et al. (2003) suggested that developmental changes in synapse morphology, including a shift from dendritic shafts to dendritic spines and compartmentalization of calcium, may underlie the changes in kinase activity.

CYTOGENETICS

Fibrolamellar hepatocellular carcinoma (see HCC, 114550) is a rare liver tumor affecting adolesce ... More on the omim web site

Subscribe to this protein entry history

June 29, 2020: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 25, 2017: Additional information
No protein expression data in P. Mayeux work for PRKACA

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 601639 was added.

Jan. 27, 2016: Protein entry updated
Automatic update: model status changed

Jan. 24, 2016: Protein entry updated
Automatic update: model status changed